Insiders · Profile

McElhaugh Michael J.

Interim President & CEO at Arbutus Biopharma. Filing since 23 Jul 2020. CIK 0001635326

Company
Date
Role
Action
Shares
Amount
Of holding
4 Feb 2025
Interim President & CEO
Sold on a plan
23,790
$78.10K
1.6%
2 Feb 2024
Interim President & CEO
Sold on a plan
10,164
$23.50K
0.7%
9 Feb 2021
Chief Business Officer
Sold, plan not stated
20,000
$100.00K
1.5%
14 Dec 2020
Chief Business Officer
Sold, plan not stated
40,000
$200.03K
2.9%
23 Jul 2020
Chief Business Officer
Sold, plan not stated
20,000
$100.20K
1.4%
5 decisions on file.